K.‐U. Seiler

415 total citations
20 papers, 324 citations indexed

About

K.‐U. Seiler is a scholar working on Pharmacology, Molecular Biology and Physiology. According to data from OpenAlex, K.‐U. Seiler has authored 20 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in K.‐U. Seiler's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Metabolism and Genetic Disorders (2 papers) and Renal function and acid-base balance (2 papers). K.‐U. Seiler is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Metabolism and Genetic Disorders (2 papers) and Renal function and acid-base balance (2 papers). K.‐U. Seiler collaborates with scholars based in Germany, Belgium and United States. K.‐U. Seiler's co-authors include O. Wassermann, Renate Lüllmann‐Rauch, Gert‐Hinrich Reil, H. Lüllmann, T. Peters, W. Niedermayer, U. Brennscheidt, G. Popken, Wolfgang Schultze‐Seemann and Ulrich Wetterauer and has published in prestigious journals such as British Journal of Pharmacology, Drugs and Atherosclerosis.

In The Last Decade

K.‐U. Seiler

18 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.‐U. Seiler Germany 11 98 85 72 42 38 20 324
L A Walker United States 9 80 0.8× 68 0.8× 131 1.8× 50 1.2× 54 1.4× 16 411
J M C Connell United Kingdom 11 81 0.8× 68 0.8× 37 0.5× 53 1.3× 89 2.3× 29 370
S. Erill Spain 13 127 1.3× 42 0.5× 45 0.6× 76 1.8× 42 1.1× 41 556
Michael Shalmi Denmark 13 224 2.3× 65 0.8× 141 2.0× 39 0.9× 45 1.2× 39 530
R. G. Spector United Kingdom 12 117 1.2× 37 0.4× 52 0.7× 51 1.2× 36 0.9× 56 398
Juro Ueda Japan 12 91 0.9× 69 0.8× 60 0.8× 25 0.6× 98 2.6× 35 328
O. Heidenreich Germany 13 187 1.9× 78 0.9× 82 1.1× 22 0.5× 65 1.7× 75 561
Norman R. Eade Canada 10 142 1.4× 73 0.9× 32 0.4× 70 1.7× 28 0.7× 19 512
Yuvenali V. Postnov Russia 8 172 1.8× 108 1.3× 26 0.4× 37 0.9× 66 1.7× 19 358
Louis Wj Australia 14 133 1.4× 76 0.9× 57 0.8× 35 0.8× 150 3.9× 29 547

Countries citing papers authored by K.‐U. Seiler

Since Specialization
Citations

This map shows the geographic impact of K.‐U. Seiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.‐U. Seiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.‐U. Seiler more than expected).

Fields of papers citing papers by K.‐U. Seiler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.‐U. Seiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.‐U. Seiler. The network helps show where K.‐U. Seiler may publish in the future.

Co-authorship network of co-authors of K.‐U. Seiler

This figure shows the co-authorship network connecting the top 25 collaborators of K.‐U. Seiler. A scholar is included among the top collaborators of K.‐U. Seiler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.‐U. Seiler. K.‐U. Seiler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seiler, K.‐U., et al.. (2008). Das pharmakokinetische Verhalten von Gold nach Gabe von Aurokeratinat. DMW - Deutsche Medizinische Wochenschrift. 105(1). 22–27.
2.
Seiler, K.‐U., E. Jähnchen, Dietmar Trenk, U. Brennscheidt, & Bernhard Heintz. (2001). Pharmacokinetics of Tilidine in Terminal Renal Failure. The Journal of Clinical Pharmacology. 41(1). 79–84. 9 indexed citations
3.
Popken, G., et al.. (2000). Intravesical administration of 5-aminolevulinic acid (5-ALA). European Journal of Clinical Pharmacology. 56(3). 241–246. 15 indexed citations
4.
Wehrmann, Till, et al.. (1997). Tilidine does not affect human sphincter of Oddi motility—a randomized, controlled study. Alimentary Pharmacology & Therapeutics. 11(5). 987–992. 4 indexed citations
5.
Seiler, K.‐U., et al.. (1994). Comparison of atorvastatin, a new HMG-CoA reductase inhibitor, with pravastatin and simvastatin. Atherosclerosis. 109(1-2). 314–314. 4 indexed citations
6.
Tebbe, Ulrich, et al.. (1991). Haemodynamic Effects of Nebivolol in Patients with Coronary Artery Disease. Clinical Drug Investigation. 3(S1). 64–68. 1 indexed citations
7.
Mönig, Heiner, et al.. (1991). Der Einfluß von Cisaprid und Metoclopramid auf die Bioverfügbarkeit von Phenprocoumon. Hämostaseologie. 11(2). 95–102. 1 indexed citations
8.
Zehender, Manfred, T. Meinertz, Annette Geibel, et al.. (1990). Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin. Multicenter Ketanserin Research Group.. PubMed. 8 Suppl 3. 90–100. 8 indexed citations
9.
Janka, H. U., H. Mehnert, Rachel M. Fisher, & K.‐U. Seiler. (1988). Influence of Ketanserin on Glucose and Lipid Metabolism in Diabetic Patients with Hypertension. Drugs. 36(Supplement 1). 123–125. 1 indexed citations
10.
Seiler, K.‐U., et al.. (1980). The Pharmacokinetics of Metoprolol and its Metabolites in Dialysis Patients. Clinical Pharmacokinetics. 5(2). 192–198. 31 indexed citations
11.
12.
Seiler, K.‐U. & O. Wassermann. (1975). Drug-induced phospholipidosis. Naunyn-Schmiedeberg s Archives of Pharmacology. 288(2-3). 261–268. 38 indexed citations
13.
Seiler, K.‐U., et al.. (1974). Drug-induced phospholipidosis. Naunyn-Schmiedeberg s Archives of Pharmacology. 283(3). 331–334. 52 indexed citations
14.
Seiler, K.‐U. & O. Wassermann. (1974). Evidence for an unusual distribution of chlorphentermine in vivo. Naunyn-Schmiedeberg s Archives of Pharmacology. 282(2). 113–122. 12 indexed citations
15.
16.
Seiler, K.‐U. & O. Wassermann. (1973). MAO-inhibitory properties of anorectic drugs. Journal of Pharmacy and Pharmacology. 25(7). 576–578. 18 indexed citations
17.
Lüllmann‐Rauch, Renate, et al.. (1972). The ultrastructure of rat lung changes induced by an anorectic drug (Chlorphentermine). Virchows Archiv B Cell Pathology. 11(1). 167–181. 71 indexed citations
18.
Lüllmann, H., et al.. (1971). A simple approach to follow the metabolic degradation of cardiac glycosides in vivo. Journal of Molecular Medicine. 49(19). 1062–1065. 1 indexed citations
19.
Lüllmann, H., T. Peters, & K.‐U. Seiler. (1971). Über die Verteilung und Biotransformation verschiedener Herzglykoside*. DMW - Deutsche Medizinische Wochenschrift. 96(23). 1018–1021. 12 indexed citations
20.
Lüllmann, H., et al.. (1971). Plasma concentration, uptake by liver, and biliary excretion of tritiated cardiac glycosides in the isolated perfused guinea‐pig liver. British Journal of Pharmacology. 41(4). 648–660. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L A Walker Breakdown of academic impact, for papers by J M C Connell Breakdown of academic impact, for papers by S. Erill Breakdown of academic impact, for papers by Michael Shalmi Breakdown of academic impact, for papers by R. G. Spector Breakdown of academic impact, for papers by Juro Ueda Breakdown of academic impact, for papers by O. Heidenreich Breakdown of academic impact, for papers by Norman R. Eade Breakdown of academic impact, for papers by Yuvenali V. Postnov Breakdown of academic impact, for papers by Louis Wj
Rankless by CCL
2026